Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
June 29, 2020
With a focus on tests, treatments, and a vaccine, we take a look at the emerging global clinical and economic evidence-base underpinning some of these technologies, the mechanisms (mostly global) for financing these commodities, and, finally, the decision-making processes for selecting technologies....
Jun
26
2020
9:00—10:30 AM EDT
June 26, 2020
Since the beginning of the COVID-19 outbreak, many health-related policy decisions have relied on epidemiologic models with a near singular focus on COVID-19 cases and deaths. Collateral health effects of COVID-19 (for example disruptions of health supply chains or avoidance of care from patients) a...
Blog Post
June 24, 2020
Using our net health impact calculator and the limited publicly available data to guide the analysis, we find that Ethiopia likely faces significant excess non-COVID-19 deaths in the coming months—possibly more than the COVID-19 deaths avoided by the government’s robust response to the pandemic.
Blog Post
June 16, 2020
Because of the uncertainties that complicate modelling, there is value in different research groups working independently to build models. Different models will employ different methods, data, and assumptions and will seek to answer different policy questions. Here we take a look from an end-user’s ...
Blog Post
June 09, 2020
Around the world COVID-19 and the policy responses to it are causing unprecedented disruptions of life and wellbeing. As scientists and governments around the world race to develop a vaccine at scale, we take a look at what a portfolio approach entails and why it is so important.
CGD NOTES
June 04, 2020
Diagnostic testing is at the center of the policy debate around COVID-19 interventions in India. As of June 1, 2020, India had conducted approximately 3.8 million tests since it began testing in February, but many experts have noted that testing capacity is still drastically insufficient for the ne...